| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 987,2 k € | +43.3% | 689,0 k € | +25.8% | 547,6 k € | +25.9% | 434,9 k € | -15.9% | 517,1 k € | +19.2% | 433,8 k € | -3.5% | 449,5 k € | +26.1% | 356,6 k € | -21.2% | 452,3 k € | +2.9% | 439,7 k € | +15.9% | 379,6 k € | -13.6% | 439,5 k € | +15.4% | 380,9 k € | -15.1% | 448,6 k € | +8.4% | 413,7 k € | +12.4% | 368,2 k € | -1.8% | 374,8 k € | +42.6% | 262,7 k € | +50.6% | 174,4 k € | |
| EBITDA | 980,7 k € | +43.4% | 684,1 k € | +25.5% | 545,1 k € | +26.0% | 432,6 k € | -15.2% | 510,4 k € | +19.4% | 427,6 k € | -3.5% | 443,2 k € | +26.5% | 350,3 k € | -21.4% | 445,4 k € | +3.1% | 432,0 k € | +15.6% | 373,9 k € | -14.0% | 434,8 k € | +15.7% | 375,8 k € | -15.2% | 443,0 k € | +8.4% | 408,7 k € | +12.6% | 363,1 k € | -1.3% | 367,8 k € | +43.0% | 257,2 k € | +49.1% | 172,5 k € | |
| Operating profit | 967,8 k € | +44.5% | 669,9 k € | +24.0% | 540,1 k € | +25.7% | 429,6 k € | -11.3% | 484,2 k € | +19.9% | 403,9 k € | -3.0% | 416,5 k € | +29.7% | 321,1 k € | -13.2% | 370,1 k € | +3.9% | 356,4 k € | +19.2% | 298,8 k € | -16.5% | 358,0 k € | +19.2% | 300,4 k € | -17.3% | 363,3 k € | +18.5% | 306,5 k € | +22.6% | 250,0 k € | -3.5% | 259,0 k € | +75.1% | 147,9 k € | +28.7% | 114,9 k € | |
| Profit/loss | 694,5 k € | +41.9% | 489,4 k € | +23.7% | 395,5 k € | +12.5% | 351,4 k € | -3.1% | 362,8 k € | +7.6% | 337,1 k € | +25.6% | 268,4 k € | +37.5% | 195,2 k € | -6.8% | 209,4 k € | -2.6% | 214,9 k € | +18.8% | 180,8 k € | -24.2% | 238,5 k € | +18.6% | 201,2 k € | -15.9% | 239,3 k € | +18.0% | 202,8 k € | +19.7% | 169,5 k € | -1.9% | 172,8 k € | +98.1% | 87,2 k € | -8.1% | 94,9 k € | |
| Equity | 2,7 M € | +19.1% | 2,2 M € | +15.2% | 1,9 M € | +10.6% | 1,8 M € | +8.5% | 1,6 M € | +12.7% | 1,4 M € | +30.7% | 1,1 M € | +32.4% | 828,4 k € | -20.9% | 1,0 M € | +25.0% | 837,8 k € | +34.5% | 623,0 k € | +40.9% | 442,1 k € | -7.2% | 476,2 k € | +0.2% | 475,1 k € | +101.5% | 235,8 k € | -29.2% | 333,0 k € | -28.2% | 463,5 k € | -14.3% | 540,7 k € | +19.2% | 453,5 k € | |
| Total assets | 2,8 M € | +21.5% | 2,3 M € | +12.7% | 2,1 M € | +11.5% | 1,9 M € | +8.9% | 1,7 M € | +11.9% | 1,5 M € | +4.2% | 1,5 M € | -1.9% | 1,5 M € | +16.6% | 1,3 M € | +20.4% | 1,1 M € | +31.4% | 808,4 k € | +8.7% | 743,6 k € | +5.9% | 702,3 k € | +2.1% | 687,9 k € | +13.6% | 605,4 k € | -19.1% | 748,7 k € | -5.4% | 791,8 k € | -14.2% | 923,0 k € | +92.4% | 479,9 k € | |
| Cash | 286,1 k € | +71.1% | 167,3 k € | -77.4% | 740,5 k € | +22.0% | 606,8 k € | +51.2% | 401,4 k € | +81.5% | 221,2 k € | -72.8% | 811,9 k € | -16.9% | 977,6 k € | -7.4% | 1,1 M € | +55.4% | 679,8 k € | +38.0% | 492,6 k € | +28.6% | 383,0 k € | +51.4% | 253,0 k € | +23.9% | 204,2 k € | +382.3% | 42,3 k € | -50.5% | 85,6 k € | +150.0% | 34,3 k € | +18.4% | 28,9 k € | +476.4% | 5,0 k € | |
| Debts | 171,3 k € | +81.4% | 94,5 k € | -14.6% | 110,6 k € | +16.8% | 94,7 k € | +14.0% | 83,0 k € | +2.6% | 80,9 k € | -76.5% | 343,9 k € | -47.0% | 649,5 k € | +194.4% | 220,6 k € | +2.3% | 215,5 k € | +21.5% | 177,3 k € | -39.6% | 293,5 k € | +35.8% | 216,2 k € | +5.7% | 204,5 k € | -43.2% | 359,9 k € | -11.6% | 407,2 k € | +29.4% | 314,6 k € | -12.7% | 360,3 k € | +2095.1% | 16,4 k € | |
Private company with limited liability · Ronse · incorporated on 01/06/2001
Private company with limited liability profitable and well capitalised. Cash position rising (+71.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Alexander - Dr. Bedert is a Private company with limited liability incorporated in 2001. Its main activity is: Other human health activities. Its registered office is in Ronse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette